Medtronic (GB:0Y6X)
UK Market

Medtronic Stock Analysis & Ratings

GB:0Y6X Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$102.17
Average Volume (3M)10.72K
Market Cap$137.07B
P/E Ratio28.2
Next EarningsMay 26, 2022
Dividend Yield2.52 (2.45%)
Smart Score8
EPS (TTM)3.63



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Medtronic’s market cap?
    Medtronic’s market cap is $137.07B.
      What is Medtronic’s price target?
      The average price target for Medtronic is $115.31. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $135.00 ,the lowest forecast is $11.45. The average price target represents 12.86% Increase from the current price of $102.17.
        What do analysts say about Medtronic?
        Medtronic’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
          When is Medtronic’s upcoming earnings report date?
          Medtronic’s upcoming earnings report date is May 26, 2022 which is in 10 days.
            How were Medtronic’s earnings last quarter?
            Medtronic released its earnings results on Feb 22, 2022. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.365 by $0.005.
              Is Medtronic overvalued?
              According to Wall Street analysts Medtronic’s price is currently Undervalued.
                Does Medtronic pay dividends?
                Medtronic pays a Quarterly dividend of $0.63 which represents an annual dividend yield of 2.45%. Medtronic’s last Quarterly dividend payment was on Apr 22, 2022. Medtronic’s upcoming ex-dividend date is Mar 24, 2022
                  What is Medtronic’s EPS estimate?
                  Medtronic’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Medtronic have?
                  Medtronic has 1,340,000,000 shares outstanding.
                    What happened to Medtronic’s price movement after its last earnings report?
                    Medtronic reported an EPS of $1.37 in its last earnings report, beating expectations of $1.365. Following the earnings report the stock price went up 2.336%.
                      Which hedge fund is a major shareholder of Medtronic?
                      Among the largest hedge funds holding Medtronic’s share is Dodge & Cox. It holds Medtronic’s shares valued at 508M.


                        Medtronic Stock Analysis

                        Smart Score
                        Price Target
                        ▲(12.86% Upside)
                        Moderate Buy
                        The Medtronic stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description


                        Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.

                        Similar Stocks
                        Price & Change
                        Abbott Labs
                        Boston Scientific
                        Johnson & Johnson

                        Popular Stocks

                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis